Medication abortion in the private sector in South Africa.
OBJECTIVE
To collect information about how private physicians in South Africa provide medication abortion services to their patients.


METHODS
In April 2003 we asked physicians in private practice in South Africa who had purchased mifepristone (Mifegyne) from the South African distributor about the medication abortion regimen they offered, satisfaction with the method, and how services have been incorporated into their practices.


RESULTS
Forty-four providers participated in the survey. They report using a range of doses and regimens. Most respondents offer mifepristone-misoprostol to their patients, although a significant minority also offer misoprostol-alone for pregnancy termination. While the majority of medication abortion providers also offer surgical abortions, a significant number of non-surgical providers were only offering medication abortion.


CONCLUSIONS
South African medication abortion providers find the method acceptable, indicate that their staff are largely supportive of offering it to their patients, and report that clients like the method. Those surveyed believe that most of their patients are eligible for the regimen, although uptake has been limited.
Blanchard
Kelly
K
Ibis Reproductive Health, Cambridge, MA 02138, USA. kblanchard@ibisreproductivehealth.org
Schaffer
Kate
K
McLeod
Shamiema
S
Winikoff
Beverly
B
D000019:Abortifacient Agents / Q000627:therapeutic use*; D000028:Abortion, Induced / Q000706:statistics & numerical data*; D005260:Female; D006176:Gynecology; D006297:Health Services Accessibility; D006801:Humans; D015735:Mifepristone / Q000627:therapeutic use; D016595:Misoprostol / Q000627:therapeutic use; D010818:Practice Patterns, Physicians'; D011247:Pregnancy; D011331:Private Practice; D013019:South Africa; D014932:Women's Health Services
D000019:Abortifacient Agents; D016595:Misoprostol; D015735:Mifepristone